GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Cyclically Adjusted PB Ratio

Societal CDMO (FRA:RAH) Cyclically Adjusted PB Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Societal CDMO Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Societal CDMO's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Cyclically Adjusted PB Ratio Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.21

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.76 0.30 0.21

Competitive Comparison of Societal CDMO's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Cyclically Adjusted PB Ratio falls into.



Societal CDMO Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Societal CDMO's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Societal CDMO's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.513/129.4194*129.4194
=0.513

Current CPI (Dec. 2023) = 129.4194.

Societal CDMO Quarterly Data

Book Value per Share CPI Adj_Book
201403 2.758 99.695 3.580
201406 2.556 100.560 3.290
201409 2.236 100.428 2.881
201412 1.992 99.070 2.602
201503 1.813 99.621 2.355
201506 1.673 100.684 2.150
201509 2.741 100.392 3.534
201512 4.016 99.792 5.208
201603 3.377 100.470 4.350
201606 2.823 101.688 3.593
201609 3.051 101.861 3.876
201612 3.565 101.863 4.529
201703 3.159 102.862 3.975
201706 2.662 103.349 3.334
201709 2.185 104.136 2.716
201712 1.274 104.011 1.585
201803 1.019 105.290 1.253
201806 1.012 106.317 1.232
201809 0.560 106.507 0.680
201812 -0.786 105.998 -0.960
201903 -0.761 107.251 -0.918
201906 -0.739 108.070 -0.885
201909 -0.798 108.329 -0.953
201912 -0.259 108.420 -0.309
202003 -0.471 108.902 -0.560
202006 -0.579 108.767 -0.689
202009 -0.543 109.815 -0.640
202012 -0.405 109.897 -0.477
202103 -0.236 111.754 -0.273
202106 0.471 114.631 0.532
202109 0.811 115.734 0.907
202112 0.797 117.630 0.877
202203 0.630 121.301 0.672
202206 0.623 125.017 0.645
202209 0.628 125.227 0.649
202212 0.619 125.222 0.640
202303 0.568 127.348 0.577
202306 0.557 128.729 0.560
202309 0.521 129.860 0.519
202312 0.513 129.419 0.513

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Societal CDMO  (FRA:RAH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Societal CDMO Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines